Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Congleton Jon sold 15,730 Mineralys Therapeutics, Inc. shares (Form 4)

Traded Apr 13, 2026 · Filed Apr 15, 2026

On Apr 13, 2026, Congleton Jon (Director, Chief Executive Officer) sold 15,730 Mineralys Therapeutics, Inc. shares at US$26.83 for US$422K under a trading plan, leaving 689,321 shares. Filed Apr 15, 2026 (Form 4).

Sold
15,730 shares
Price
US$26.83
Value
US$422K
Holding after
689,321 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 13, 2026Common StockSale15,730US$26.83689,321Direct

Source

View original at SEC

Related